Back to Search

JEANNY ARAGON-CHING, M.D.

M.D.

Medical Oncology Physician

NPI: 1376701946IndividualAccepts Medicare

Specialties, Licenses & Credentials

Medical Oncology PhysicianPrimary

Internal Medicine — Medical Oncology

Code: 207RX0202X

0101258348(VA)
Internal Medicine Physician

Internal Medicine

Code: 207R00000X

0101258348(VA)
Hematology (Internal Medicine) Physician

Internal Medicine — Hematology

Code: 207RH0000X

0101258348(VA)
Hematology & Oncology Physician

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

MD037179(DC)

CMS Specialties

PrimaryHEMATOLOGY/ONCOLOGY

Education

OTHER

Class of 1997

Research & Publications (17)

VEGF inhibitors and prostate cancer therapy.
PMID 19617926·Curr Mol Pharmacol·2009
6-review
Phase I study of oral lenalidomide in patients with refractory metastatic cancer.
PMID 19451403·J Clin Pharmacol·2009
3-trial
Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.
PMID 19235596·Cancer Invest·2009
3-trial
Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy.
PMID 19228742·Clin Cancer Res·2009
8-other
A double-blind randomized crossover study of oral thalidomide versus placebo for androgen dependent prostate cancer treated with intermittent androgen ablation.
PMID 19167733·J Urol·2009
2-rct
Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer.
PMID 19154507·BJU Int·2009
3-trial
Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association?
PMID 19088325·Oncologist·2008
8-other
Kinetics of serum androgen normalization and factors associated with testosterone reserve after limited androgen deprivation therapy for nonmetastatic prostate cancer.
PMID 18710748·J Urol·2008
3-trial
ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel.
PMID 18628469·Clin Cancer Res·2008
8-other
Acute aortic dissection in a hypertensive patient with prostate cancer undergoing chemotherapy containing bevacizumab.
PMID 18607842·Acta Oncol·2008
5-case

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Via practice · 3 locations total

Address
8081 INNOVATION PARK DR
FAIRFAX, VA 22031

Locations (3)

Practice Location

8081 INNOVATION PARK DR, FAIRFAX, VA
(571) 472-4724

Practice Location

3300 GALLOWS RD, FALLS CHURCH, VA
(703) 776-4001

Practice Location

44055 RIVERSIDE PKWY STE 108, LEESBURG, VA
(703) 858-8600

Quick Facts

NPI
1376701946
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
4
Locations
3
Years in Practice
29
Publications
17

Are you this provider?

Claim Your Profile